Munich, Germany

Sven Bresch

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sven Bresch: Innovator in Enzymatic Processes

Introduction

Sven Bresch is a notable inventor based in Munich, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of enzyme mutants for various applications. With a total of two patents to his name, Bresch's work is recognized for its innovative approach to enzymatic reactions.

Latest Patents

Sven Bresch's latest patents include the invention of 7β-hydroxysteroid dehydrogenase mutants and a process for the preparation of ursodeoxycholic acid. The first patent provides a nucleic acid molecule that encodes a 7β-hydroxysteroid dehydrogenase (7β-HSDH) mutant. This mutant is designed to catalyze the stereospecific enzymatic reduction of a 7-ketosteroid to the corresponding 7-hydroxysteroid. Notably, the mutant exhibits decreased substrate inhibition and altered cofactor usage compared to the wildtype 7β-HSDH. The second patent focuses on novel processes for synthesizing ursodeoxycholic acid using these enzyme mutants, highlighting their utility in enzymatic reactions involving cholic acid compounds.

Career Highlights

Sven Bresch is currently employed at Pharmazell GmbH, where he continues to advance his research in enzymatic processes. His work has positioned him as a key figure in the development of innovative biotechnological solutions. Bresch's contributions are vital to the pharmaceutical industry, particularly in the synthesis of important compounds.

Collaborations

Sven has collaborated with notable colleagues such as Dirk Weuster-Botz and Michael Braun. These partnerships have fostered a collaborative environment that enhances the research and development of new enzymatic processes.

Conclusion

Sven Bresch's innovative work in the field of biochemistry, particularly through his patents on enzyme mutants, showcases his commitment to advancing scientific knowledge and applications. His contributions are significant in the ongoing development of biotechnological solutions in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…